Clinical · Molecular biology
Identification of Novel Pathogenic Variants in Familial Adenomatous Polyposis Through Whole Genome Sequencing
Summary
This study investigated the use of whole genome sequencing (WGS) to identify pathogenic variants previously undetected by routine genetic testing in patients with unexplained familial adenomatous polyposis (FAP). Researchers discovered two novel APC gene variants: a large deletion encompassing exon 10 and a deep intronic complex deletion-insertion variant. These variants were validated at the transcript level, confirming their impact on splicing and leading to truncated protein production. The findings underscore the importance of WGS and RNA-based analysis for comprehensive genetic diagnosis of FAP.
Critical appraisal
Clinical. This study has immediate clinical impact by demonstrating that whole genome sequencing (WGS) can resolve familial adenomatous polyposis (FAP) cases that remain genetically unexplained by targeted panels or whole exome sequencing. Integrating WGS, combined with RNA-level validation, could significantly improve the diagnostic yield for FAP patients, enabling better risk stratification and tailored clinical management. This would justify clinical trials evaluating the diagnostic efficacy and cost-effectiveness of WGS as a first or second-line test for atypical or unresolved FAP cases, with potential clinical impact within 3-5 years.
Molecular biology. The discovery of cryptic pathogenic variants in the APC gene, specifically a large exon 10 deletion and a deep intronic complex deletion-insertion variant, highlights the limitations of conventional sequencing technologies. The study utilized WGS for detecting these structural and deep intronic variants, complemented by transcriptomic validation techniques such as RT-PCR, Sanger sequencing, and RT-qPCR. This combined approach demonstrated the functional impact of these variants on splicing and truncated protein production, thereby validating their pathogenicity. The methodology underscores the importance of RNA analysis for variant interpretation, especially for deep intronic splicing variants, and paves the way for clinical tests integrating WGS and RNA analysis for more comprehensive variant detection.
The summary and the appraisal were written by a language model from the title and abstract of the original article. A curator decided to publish it. Methodology